Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Myeloid 1Gastrointestinal 1Classical hematology 1

Conditions

Myelodysplastic Syndromes 355Leukemia, Myeloid, Acute 297Myeloproliferative Disorders 155Leukemia, Myelogenous, Chronic, BCR-ABL Positive 139Precursor Cell Lymphoblastic Leukemia-Lymphoma 115Primary Myelofibrosis 101Leukemia, Myelomonocytic, Chronic 88Lymphoma, Non-Hodgkin 76Leukemia 69Polycythemia Vera 61Multiple Myeloma 55Hodgkin Disease 50Hematologic Neoplasms 48Leukemia, Lymphocytic, Chronic, B-Cell 43Lymphoma 40Leukemia, Biphenotypic, Acute 40Thrombocythemia, Essential 39Myelodysplastic-Myeloproliferative Diseases 31Neoplasms 29Leukemia, Myeloid, Chronic-Phase 28Anemia, Refractory, with Excess of Blasts 24Recurrence 22Anemia, Aplastic 21Lymphoma, Mantle-Cell 20Lymphoma, Follicular 20Hematologic Diseases 20Burkitt Lymphoma 20Blastic Plasmacytoid Dendritic Cell Neoplasm 20Blast Crisis 20Histiocytosis, Langerhans-Cell 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Splenomegaly × Myeloid × 1 year × Clear all
NCT07379125 2026-05-22

Therapeutic RSK1 Targeting in Myelofibrosis

Washington University School of Medicine

Phase 1 Recruiting
18 enrolled
Classical hematologyMyeloid

Anemia, Bone Marrow Diseases, Hematologic Diseases, Myeloproliferative Disorders, Splenomegaly, Bone Marrow Neoplasms, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡